Literature DB >> 12490859

Elevated serum parathormone level after "concise parathyroidectomy" for primary sporadic hyperparathyroidism.

Sally E Carty1, Michelle M Roberts, Mohamed A Virji, Laura Haywood, John H Yim.   

Abstract

BACKGROUND: Cure after parathyroid exploration is traditionally assessed by serum calcium concentration 6 months postoperatively. Postoperative normocalcemic elevation of serum parathormone (PTH) level has been described but is of unclear significance.
METHODS: In a 6-year prospective study of outcomes in 380 patients undergoing initial parathyroidectomy for primary sporadic hyperparathyroidism, we measured intact serum PTH and calcium levels at more than 5 months. Those with normocalcemic high PTH levels were begun on oral calcium + vitamin supplements and monitored.
RESULTS: At more than 5 months postoperatively, normocalcemic elevation in serum PTH level occurred in 28% of patients, was more common after resection of double adenomas (P =.01), and predated the onset of recurrent hypercalcemia in 3 of 3 patients with unrecognized multiglandular disease. Although delayed treatment with calcium and vitamin supplements produced no clear benefit, patients who took such supplements from the date of surgery were much less likely to have an elevated serum PTH level more than 5 months later (P =.0005).
CONCLUSIONS: After successful parathyroid surgery, compensatory normocalcemic elevation in serum PTH level is frequent and may arise from dietary deficiency. Monitored supplemental intake of calcium and vitamin D appears to prevent or to normalize the condition in most patients. Patients with normocalcemic elevation in serum PTH level should receive evaluation for dietary deficiencies as well as follow-up for possible residual disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12490859     DOI: 10.1067/msy.2002.128479

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  24 in total

1.  Elevated parathyroid hormone after parathyroidectomy delays symptom improvement.

Authors:  Priya R Pathak; Sara E Holden; Sarah C Schaefer; Glen Leverson; Herbert Chen; Rebecca S Sippel
Journal:  J Surg Res       Date:  2014-03-02       Impact factor: 2.192

2.  Unilateral surgery for hyperparathyroidism: indications, limits, and late results--new philosophy or expensive selection without improvement of surgical results?

Authors:  Pierre-E Mortier; Marta M Mozzon; Olivier P Fouquet; Benoit C Soudan; Damien G Huglo; Jean-F Cussac; Charles A G Proye
Journal:  World J Surg       Date:  2004-11-11       Impact factor: 3.352

3.  Sestamibi SPECT intensity scoring system in sporadic primary hyperparathyroidism.

Authors:  Linwah Yip; Daniel A Pryma; John H Yim; Sally E Carty; Jennifer B Ogilvie
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

4.  Minimal invasive parathyroidectomy with local anesthesia for well-localized primary hyperparathyroidism: "Cerrahpasa experience".

Authors:  Serkan Teksoz; Yusuf Bukey; Murat Ozcan; Akif Enes Arikan; Safak Emre Erbabacan; Ates Ozyegin
Journal:  Updates Surg       Date:  2013-02-21

5.  Normalization of 2-week postoperative parathyroid hormone values in patients with primary hyperparathyroidism: four-gland exploration compared to focused-approach surgery.

Authors:  Peter J Mazzaglia; Mira Milas; Eren Berber; Alan Siperstein; Jack M Monchik
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

6.  The impact of vitamin D status and tumor size on the intraoperative parathyroid hormone dynamics in patients with symptomatic primary hyperparathyroidism.

Authors:  Gaurav Agarwal; Dhalapathy Sadacharan; Pooja Ramakant; Manoj Shukla; Saroj K Mishra
Journal:  Surg Today       Date:  2012-01-05       Impact factor: 2.549

Review 7.  Elevated parathyroid hormone levels after successful parathyroidectomy for primary hyperparathyroidism: a clinical review.

Authors:  Roberto de la Plaza Llamas; José Manuel Ramia Ángel; Vladimir Arteaga Peralta; Cristina García Amador; Aylhín Joana López Marcano; Aníbal Armando Medina Velasco; Begoña González Sierra; Alba Manuel Vázquez; Raquel Aránzazu Latorre Fragua
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-05       Impact factor: 2.503

8.  Persistently Elevated PTH After Parathyroidectomy at One Year: Experience in a Tertiary Referral Center.

Authors:  Marie Caldwell; Jeff Laux; Marshall Clark; Lawrence Kim; Janet Rubin
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

9.  The final intraoperative parathyroid hormone level: how low should it go?

Authors:  Laura I Wharry; Linwah Yip; Michaele J Armstrong; Mohamed A Virji; Michael T Stang; Sally E Carty; Kelly L McCoy
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

10.  Progress in the operative management of sporadic primary hyperparathyroidism over 34 years.

Authors:  George L Irvin; Denise M Carneiro; Carmen C Solorzano
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.